Terms: = Germ cell tumor AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
17287 results:
1. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
2. The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings.
Hammad R; Nobre L; Ryall S; Arnoldo A; Siddaway R; Bennett J; Tabori U; Hawkins C
JCO Glob Oncol; 2024 May; 10():e2300269. PubMed ID: 38754050
[TBL] [Abstract] [Full Text] [Related]
3. Hearing preservation surgery for vestibular schwannoma: a systematic review and meta-analysis.
Pontillo V; Foscolo V; Salonna F; Barbara F; Bozzi MT; Messina R; Signorelli F; Quaranta NAA
Acta Otorhinolaryngol Ital; 2024 May; 44(Suppl. 1):S86-S93. PubMed ID: 38745520
[TBL] [Abstract] [Full Text] [Related]
4. Sporadic subependymal giant cell astrocytoma with somatic
Alassiri AH; Alfayea TM; Aljared TI; Alenezi KR
Neurosciences (Riyadh); 2024 May; 29(2):139-143. PubMed ID: 38740392
[TBL] [Abstract] [Full Text] [Related]
5. Understanding supported self-management for people living with a lower-grade glioma: Implementation considerations through the lens of normalisation process theory.
Rimmer B; Finch T; Balla M; Dutton L; Williams S; Lewis J; Gallagher P; Burns R; Araújo-Soares V; Menger F; Sharp L;
Health Expect; 2024 Jun; 27(3):e14073. PubMed ID: 38733245
[TBL] [Abstract] [Full Text] [Related]
6. Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation.
Khandalavala KR; Herberg HA; Kay-Rivest E; Moore LS; Yancey KL; Marinelli JP; Lund-Johansen M; Kosaraju N; Lohse CM; Kutz W; Santa Maria PL; Golfinos JG; Kondziolka D; Carlson ML; Tveiten ØV; Link MJ
Otol Neurotol; 2024 Jun; 45(5):587-593. PubMed ID: 38728563
[TBL] [Abstract] [Full Text] [Related]
7. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
[TBL] [Abstract] [Full Text] [Related]
8. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
[TBL] [Abstract] [Full Text] [Related]
9. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
10. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
Liu Z; Yu L; Lai J; Zhang R
Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
[TBL] [Abstract] [Full Text] [Related]
11. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
[TBL] [Abstract] [Full Text] [Related]
12. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
[TBL] [Abstract] [Full Text] [Related]
13. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
[TBL] [Abstract] [Full Text] [Related]
14. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma.
Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA
Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858
[TBL] [Abstract] [Full Text] [Related]
15. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
[TBL] [Abstract] [Full Text] [Related]
16. The burden of skull base chordomas: insights from a meta-analysis of observational studies.
Fiore G; Porto E; Bertani GA; Marcus HJ; Saladino A; Pradilla G; DiMeco F; Locatelli M
Neurosurg Focus; 2024 May; 56(5):E13. PubMed ID: 38691853
[TBL] [Abstract] [Full Text] [Related]
17. Long-term outcome of primary clival chordomas: a single-center retrospective study with an emphasis on the timing of recurrences based on the primary treatment.
Hong S; Shinya Y; Mahajan A; Laack NN; O'Brien EK; Stokken JK; Janus JR; Raghunathan A; Link MJ; Van Gompel JJ
Neurosurg Focus; 2024 May; 56(5):E4. PubMed ID: 38691852
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
19. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
[TBL] [Abstract] [Full Text] [Related]
20. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
[Next]
